Epidemiology of inclusion body myositis in the Netherlands: a nationwide study

U. A. Badrising; M. Maat-Schieman; S. G. van Duinen; F. Breedveld; P. van Doorn; B. van Engelen; F. van den Hoogen; J. Hoogendijk; C. Höweler; A. de Jager; F. Jennekens; P. Koehler; H. van der Leeuw; M. de Visser; J. J. Verschuuren; A. R. Wintzen

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study

U. A. Badrising, M. Maat-Schieman, S. G. van Duinen, F. Breedveld, P. van Doorn, B. van Engelen, F. van den Hoogen, J. Hoogendijk, C. Höweler, A. de Jager, F. Jennekens, P. Koehler, H. van der Leeuw, M. de Visser, J. J. Verschuuren, A. R. Wintzen

Other Departments

Research output: Contribution to journal › Article › Academic › peer-review

175 Citations (Scopus)

Abstract

Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present nationwide collaborative cross-sectional study, which culminated on July 1, 1999, resulted in identification of 76 patients with IBM and the establishment of a prevalence of 4.9 patients with IBM per million inhabitants in the Netherlands. Several discrepancies suggest that this may be an underestimation. The most frequently identified pitfall in diagnosing IBM was an erroneous diagnosis of polymyositis or motor neuron disease

Original language	English
Pages (from-to)	1385-1387
Journal	Neurology
Volume	55
Issue number	9
Publication status	Published - 2000

Cite this

Badrising, U. A., Maat-Schieman, M., van Duinen, S. G., Breedveld, F., van Doorn, P., van Engelen, B., van den Hoogen, F., Hoogendijk, J., Höweler, C., de Jager, A., Jennekens, F., Koehler, P., van der Leeuw, H., de Visser, M., Verschuuren, J. J., & Wintzen, A. R. (2000). Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology, 55(9), 1385-1387.

@article{812665bf4b7643a9b38557e82f81aa11,

title = "Epidemiology of inclusion body myositis in the Netherlands: a nationwide study",

abstract = "Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present nationwide collaborative cross-sectional study, which culminated on July 1, 1999, resulted in identification of 76 patients with IBM and the establishment of a prevalence of 4.9 patients with IBM per million inhabitants in the Netherlands. Several discrepancies suggest that this may be an underestimation. The most frequently identified pitfall in diagnosing IBM was an erroneous diagnosis of polymyositis or motor neuron disease",

author = "Badrising, {U. A.} and M. Maat-Schieman and {van Duinen}, {S. G.} and F. Breedveld and {van Doorn}, P. and {van Engelen}, B. and {van den Hoogen}, F. and J. Hoogendijk and C. H{\"o}weler and {de Jager}, A. and F. Jennekens and P. Koehler and {van der Leeuw}, H. and {de Visser}, M. and Verschuuren, {J. J.} and Wintzen, {A. R.}",

year = "2000",

language = "English",

volume = "55",

pages = "1385--1387",

journal = "Neurology",

issn = "0028-3878",

publisher = "American Academy of Neurology",

number = "9",

}

Badrising, UA, Maat-Schieman, M, van Duinen, SG, Breedveld, F, van Doorn, P, van Engelen, B, van den Hoogen, F, Hoogendijk, J, Höweler, C, de Jager, A, Jennekens, F, Koehler, P, van der Leeuw, H, de Visser, M, Verschuuren, JJ & Wintzen, AR 2000, 'Epidemiology of inclusion body myositis in the Netherlands: a nationwide study', Neurology, vol. 55, no. 9, pp. 1385-1387.

TY - JOUR

T1 - Epidemiology of inclusion body myositis in the Netherlands: a nationwide study

AU - Badrising, U. A.

AU - Maat-Schieman, M.

AU - van Duinen, S. G.

AU - Breedveld, F.

AU - van Doorn, P.

AU - van Engelen, B.

AU - van den Hoogen, F.

AU - Hoogendijk, J.

AU - Höweler, C.

AU - de Jager, A.

AU - Jennekens, F.

AU - Koehler, P.

AU - van der Leeuw, H.

AU - de Visser, M.

AU - Verschuuren, J. J.

AU - Wintzen, A. R.

PY - 2000

Y1 - 2000

N2 - Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present nationwide collaborative cross-sectional study, which culminated on July 1, 1999, resulted in identification of 76 patients with IBM and the establishment of a prevalence of 4.9 patients with IBM per million inhabitants in the Netherlands. Several discrepancies suggest that this may be an underestimation. The most frequently identified pitfall in diagnosing IBM was an erroneous diagnosis of polymyositis or motor neuron disease

AB - Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present nationwide collaborative cross-sectional study, which culminated on July 1, 1999, resulted in identification of 76 patients with IBM and the establishment of a prevalence of 4.9 patients with IBM per million inhabitants in the Netherlands. Several discrepancies suggest that this may be an underestimation. The most frequently identified pitfall in diagnosing IBM was an erroneous diagnosis of polymyositis or motor neuron disease

M3 - Article

C2 - 11087787

SN - 0028-3878

VL - 55

SP - 1385

EP - 1387

JO - Neurology

JF - Neurology

IS - 9

ER -